Prime Global

Prime Global, a recognised global leader in medical communications, evidence and access, and patient engagement, has acquired earthware, an award-winning creative digital agency that creates life-changing solutions to real world healthcare problems. earthware joins Prime Global in supporting pharma and biotech clients at every step of the healthcare journey; their industry-leading technology expertise will complement

At Prime Global, we are passionate about ensuring our operations are sustainable. We are proud to be working together with travel supplier Gray Dawes, in partnership with Forest Carbon, to provide our people with an international carbon offset programme for all business travel.

An estimated 57.4 million people live with dementia worldwide, (1) and unfortunately, clinical trials for dementia treatments have resulted in few pharmacotherapies – none of them curative. (2) (3) (4) For World Alzheimer’s Day, Prime Patient explore how Pharma can collaborate with people living with dementia to optimise the industry’s dementia research and patient community

Have hybrid congresses reached their full potential in providing a true omnichannel experience? Michelle Collins, Head of Digital Solutions at Prime Global, discusses.

The working day accounts for a lot of our time. On average, over a third of people’s days are spent at work. Because of this, it is extremely important we ensure we are spending this time in a place that is enjoyable and rewarding to work at.

We are delighted to have been featured in MM+M’s article, A medical marketing blind spot: LGBTQIA+ communities being left behind.

Many agree that disability inclusion in clinical trials is a worthy pursuit, but the historical significance and future impact of pursuing this goal is relatively unexplored. Here, we peel back the layers of this vital mission.

At Prime Global, we are committed to supporting charities and causes that have a direct impact on our communities. This year, we organised the Prime Global Walking Challenge, a virtual walking challenge as part of our ESG initiative to help raise money for the Rainforest Action Network.

We take a look at the value of patient data, how it can impact Pharma and to what extent it could benefit the industry.

We caught up with Senior Health Economist Idaira Rodriguez Santana, to find out more about her role as well as her biggest achievements so far!

For Pride Month 2022, Prime Patient investigate how Pharma can build stronger, more productive relationships with the LGBTQIA+ community 

This Pride Month, Prime Patient takes a close look at the health inequity faced by the transgender community, and what we can do about it. 

A very warm welcome to the latest cohort of our entry-level training programme, IGNITE. This marks the seventh round since the programme’s inception in 2017, and features trainees across our Medical Communications and Evidence, Access, and Patient practice areas.

This month, the results of the 2021 PatientView corporate reputation survey were released. With insights from 240 US patient groups, a number of key findings were reported; here, we take a closer look.

On May 24th, the Prime Patient team was fortunate to have a spot at 2022’s Patient Centricity and Engagement Conference, hosted in London, England. With a veritable smorgasbord of topics up for discussion, we were spoiled for choice! Here we summarise some highlights from the day, kicking off with tips on strengthening patient advocacy collaboration. 

Analysis of the molecular landscape that characterises a patient or disease is an evolving area that is increasingly driving discoveries in healthcare.

Haemophilia is a lifelong genetic disorder characterised by excessive bleeding.(1) Despite the existence of treatments for haemophilia, the condition continues to have major impacts on quality of life, for example in the areas of pain (acute and chronic), joint mobility, and physical function.(1) To mark World Haemophilia Day on 17 April, Prime Patient partnered with

Prime Patient team up with Jess Duggan from the SynGAP Research Fund to better understand what this advocacy group wants Pharma to know this Developmental Disabilities Awareness Month.

Prime Patient collaborate with award-winning advocate Trishna Bharadia to explore how industry can better engage with people living with multiple sclerosis (PwMS) this MS Awareness Month. 

We caught up with Senior Account Executive Pamela Lopez, to find out more about her role and our Ignite scheme!

Patient advocacy and engagement are important no matter the disease area, whether it’s a common condition or one that few have heard of. Following the recent celebration of Rare Disease Day, let’s take a closer look at patient engagement in rare mutation cancers. 

In the spirit of Rare Disease Day, which was celebrated on 28 February, we’re looking at the importance of patient engagement in lysosomal storage disorders (LSDs).

Medical publishing is evolving beyond plain language summaries to provide insightful, patient-centred resources to change the course of pharmaceutical research for the better. For patients with rare diseases especially, this could be just what the doctor ordered, writes Olivia Kersey, Patient Engagement Strategist with Prime Patient.

Emma Sutcliffe, SVP Patient Insights and Solutions, Prime Patient shares her reflections about whether the pandemic has helped or hindered patient engagement and research for rare diseases.

We chat with Digital Health Consultant, Barnaby Poulton, about how technology can help amplify the patient voice.

To celebrate International Day of Women and Girls in Science, some of our brilliant women are sharing advice about achieving career goals, how they started their career in medcomms and their experience of being a woman of science.

This year’s ISMPP Europe meeting was action packed, with Prime Global sending 5 team members, presenting 5 posters, sharing 7 publication extenders, and moderating 2 roundtables! Here, we share some of our key highlights from the conference. 

Olivia Kersey, Patient Engagement Strategist, outlines what we can learn from 2021 to optimise patient engagement strategy and implementation in 2022. While there would be no such thing as the pharmaceutical industry without patients, it’s only in recent years that collaboration with patients has started to enter the mainstream. While 2021 was a good year

The Prime Patient team are proud to have had a poster accepted for presentation at the 2022 European meeting of ISMPP (International Society for Medical Publication Professionals), held virtually on 25-26 January. The poster, one of five accepted across Prime Global, presents the results of an internal survey that aimed to identify barriers and solutions

Prime Global, a recognised global leader in medical communications and market access, has strengthened its Evidence, Access, and Patient Practice with the acquisition of HCD Economics, an academically aligned organisation focusing on health economics and outcomes research (HEOR) and real-world evidence (RWE). HCD will work closely with Prime Global’s highly experienced medical communications agencies and